-
HiJAKing Gamma Chain Cytokine Signaling for CAR T Cell Therapy
The engineering of chimeric antigen receptor (CAR) T cells has been a significant recent advance in cancer therapy. CAR T cells are manufactured by collecting a patient’s own T cells, engineering these T cells to express a synthetic signaling molecule (the CAR) that specifically redirects the T cell response towards cancer cells, and re-infusing the…
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
BioBuzz 